Tyers Asset Management’s Medicines Co MDCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$717K Buy
14,336
+672
+5% +$26.8K 0.02% 389
2019
Q2
$498K Buy
13,664
+392
+3% +$12.8K 0.02% 480
2019
Q1
$371K Hold
13,272
0.01% 545
2018
Q4
$254K Buy
13,272
+2,996
+29% +$69.7K 0.01% 602
2018
Q3
$307K Buy
10,276
+2,072
+25% +$78.1K 0.01% 631
2018
Q2
$301K Buy
8,204
+364
+5% +$11.8K 0.01% 574
2018
Q1
$258K Hold
7,840
0.01% 604
2017
Q4
$214K Buy
7,840
+1,120
+17% +$34.5K 0.01% 666
2017
Q3
$249K Buy
6,720
+924
+16% +$34.1K 0.01% 579
2017
Q2
$220K Buy
5,796
+2,492
+75% +$111K 0.01% 583
2017
Q1
$162K Buy
3,304
+364
+12% +$16.6K 0.01% 567
2016
Q4
$100K Buy
+2,940
New +$104K ﹤0.01% 646

Other funds holding MDCO

Tyers Asset Management's MDCO Position: Q3 2019 in Review

Tyers Asset Management increased its Medicines Co (MDCO) stake by 4.9% in Q3 2019, buying an estimated $26.8K and bringing the position to 14,336 shares worth $717K. The position accounts for 0.02% of the portfolio, ranked #389.

Tyers Asset Management first reported a position in MDCO in Q4 2016 and has held it in 12 quarters since. 250 funds tracked by Wall St. Rank hold MDCO as of Q3 2019.

  • Tyers Asset Management held 14,336 shares of Medicines Co worth $717K as of Q3 2019.
  • Tyers Asset Management bought 672 Medicines Co shares in Q3 2019, an estimated $26.8K.
  • Medicines Co made up 0.02% of Tyers Asset Management's portfolio in Q3 2019, its #389 holding.
  • Tyers Asset Management first reported a position in Medicines Co in Q4 2016 and has held it in 12 quarters since.
  • 250 funds tracked by Wall St. Rank held Medicines Co as of Q3 2019.

Based on Tyers Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.